icn pharmaceuticals inc said its board approved purchase three mln shares its outstanding common stock icn also said plans buy 500 000 more shares each viratek inc and spi pharmaceuticals inc icn said buyback plans were approved because board believed current prices investment represented icn group itself best interests shareholders company reuter 